secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aptose Biosciences Inc. (APTOF)
CIK:        0000882361
Form:       8-K
Filed at:   2025-08-27T23:59:59+00:00
Accession:  0001193125-25-189846
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptose Biosciences appoints EY as independent auditor, replacing KPMG
---------------------------------------------------------------------

- KPMG informed company it would not stand for re-appointment for 2025 annual audit.
- Board approved EY as independent auditor; shareholders voted approval at reconvened meeting on August 22, 2025.
- No disagreements or reportable events between company and KPMG during past two fiscal years.
- KPMG letter agreeing with disclosures attached as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882361/000119312525189846/0001193125-25-189846-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882361/000119312525189846/d96555d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-189846

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer